Always store it properly, follow the expiration guidelines, and pay attention to any changes in the medications appearance
This trial tests a new treatment called retatrutide (a GLP-1/GIP/glucagon tri-agonist) to assess its effects on kidney function in individuals who are overweight or have obesity and chronic kidney disease
If you dont prioritize changing your lifestyle habits while taking a GLP-1, when you go off the medication, the likelihood of regaining weight is high
While the effects do not occur instantly, you may begin to notice some of the changes below within the first 8 weeks of therapy
In mid-2023, reports of suicidal ideation and behavior in patients taking GLP-1s prompted regulators around the world to look into such risk
In patients using GLP-1s, retention of contents in the GI tract can lead to fermentation of gut contents, gas overproduction, and abdominal discomfort